Inventor · disambiguated record
Bruce Follows
Also filed as: FOLLOWS BRUCE · FOLLOWS BRUCE C · FOLLOWS BRUCE CHRISTOPHER
30 granted patents·11 pending applications·292 citations·filing 2005–2025
97Inventor score
Files withFORMA THERAPEUTICS INC23VALO EARLY DISCOVERY INC8KYMERA THERAPEUTICS INC4VALO HEALTH INC2WYETH CORP2
Top patents by PatentIndex Score
41 records- 0197US9840491B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Dec 12, 2017·22 cites·17 claims
- 0296US10377767B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·16 cites·16 claims
- 0396US10377773B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·18 cites·16 claims
- 0496US10000495B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Jun 19, 2018·21 cites·16 claims
- 0596US9938300B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·23 cites·15 claims
- 0696US9932351B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 3, 2018·24 cites·12 claims
- 0796US9902728B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·24 cites·40 claims
- 0895US12091411B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·5 cites·9 claims
- 0995US10934299B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Mar 2, 2021·7 cites·20 claims
- 1095US10377760B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·17 cites·20 claims
- 1195US10351571B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·15 cites·17 claims
- 1294US10519129B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1394US10519127B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·24 claims
- 1494US10519130B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1594US10519128B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·19 claims
- 1694US10513507B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·9 cites·20 claims
- 1794US10513508B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·8 cites·30 claims
- 1894US10508098B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·8 cites·20 claims
- 1993US10906916B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 2, 2021·4 cites·16 claims
- 2089US7521473B2Inhibitors of protein tyrosine phosphatase 1BWYETH CORP·Filed 2005·Granted Apr 21, 2009·23 cites·59 claims
- 2188US10836741B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 17, 2020·3 cites·28 claims
- 2287US10927130B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 23, 2021·4 cites·16 claims
- 2385US10981915B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 20, 2021·3 cites·12 claims
- 2483US10399980B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 2583US10189841B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jan 29, 2019·3 cites·11 claims
- 2681US11161848B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·1 cites·26 claims
- 2776US11739071B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2020·Granted Aug 29, 2023·0 cites·20 claims
- 2876US2025011325A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2975US12043623B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·0 cites·20 claims
- 3075US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3173US11795171B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsVALO HEALTH INC·Filed 2021·Granted Oct 24, 2023·0 cites·10 claims
- 3272US12018030B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO HEALTH INC·Filed 2021·Granted Jun 25, 2024·0 cites·16 claims
- 3372US2021292337A1Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3471US2021323978A1Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3561US2009048286A1Inhibitors of Protein Tyrosine Phosphatase 1BWYETH CORP·Filed 2008·Application pending·0 cites
- 3658US2025213586A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3754US2021346356A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3851US2005203081A1Inhibitors of protein tyrosine phosphatase 1BFiled 2005·Application pending·0 cites
- 3948US2022041597A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4046US2023065368A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4132US2011105509A1Indole based receptor crth2 antagonistsWYETH LLC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →